Skip to Content
You are currently on the new version of our website. Access the old version .
MolbankMolbank
  • Short Note
  • Open Access

31 May 2007

2 Pages

Synthesis of Ethyl [4-(2-chlorobenzyl)-3-methyl-6-oxopyridazin-1(6H)-yl]acetate

,
,
,
and
Department of Chemistry, University Mohamed I, Sciences Faculty, 60000 Oujda, Morocco
*
Author to whom correspondence should be addressed.
Pyridazines are of chemical and biological interest. They have been reported to be anticonvulsive agents [1], Furthermore, Gehrlein et al. have described the antihypertensive effects of novel hydroxyethylpyridazine compounds [2]. In continuation of this line of investigation, we have synthesized compound (I); it will be subjected to further pharmacological investigations, especially tests of its anticancer activity.
The product (II) was prepared from 5-(2-chlorobenzyl)-6-methylpyridazin-3(2H)-one (I) in situ by the solid-liquid PTC conditions without solvent [3]. To pyridazin (I) (1.4 g, 6 mmol) was added (2.75 g, 9 mmol) of potassium carbonate, (0.3 g, 1 mmol) of TBAB and (1 g, 6 mmol) of 2-ethyl bromoacetate. The mixture was placed in a pyrex tube which was then introduced into a Maxidigest MX 350 Prolabo microwave monomode reactor fitted with a rotational system. At the end of the irradiation time (10 min on 90 w as irradiation power), the mixture was cooled to ambient temperature. After elution with ethyl acetate (30 ml) and subsequent filtration on florisil, the organic product was purified by chromatography on silica gel using CH2Cl2 as eluent, yield: 92 % of (II) solid.
Melting point: 89-90°C
IR (KBr, cm−1): 1747 (CO2Et), 1670 (C=O), 1605, 1470, 1210 (C = N)
1H-NMR (300.14 MHz, CDCl3) d (ppm): 1.28 (t, J = 7.5 Hz, 3H, CH3), 2.31(s, 3H, CH3), 3.38 (s, 2H, CH2), 4.25 (q, J = 5 Hz, 2H, CH2), 4.82 (s, 2H, CH2), 6.32 (s, 1H, H4), 7.20 (m, 4H, aromatic protons).
13C-NMR (75 MHz, CDCl3) d (ppm):14.11 (CH3), 19.03 (CH3) 35.77 (CH2), 52.68 (CH2), 61.66 (CH2), 127.71 (CH o), 127.42(CH aromatic), 129.02 (CH aromatic), 130.02 (CH aromatic), 131, 12 (CH aromatic) 134.43, 144.97, 145.17, 160.30 (C3), 167.72 (C=O).
MS m/z (%) (M+1)+ = 321.5, 279, 275,219.

Supplementary materials

Supplementary File 1Supplementary File 2Supplementary File 3

References:

  1. Foussard-Blanc, P.; Lacroix, R. Moniteur Int. 1991, 25, 71–84.
  2. Gehrlein, L.; Powers, L.J.; Eckert, D.J. J. Pharm. Sci. 1981, 70, 419–422.
  3. (a) Kappe, C.O.; Dallinger, D. Nature Reviews Drug Discovery 2006, 5, 51. ; (b) De la Hoz, A.; Diaz-Ortiz, A.; Moreno, A. Chem. Soc. Rev. 2005, 34, 164.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.